Snodgrass B
Curr Oncol. 2018; 25(2):e183.
PMID: 29719444
PMC: 5927799.
DOI: 10.3747/co.25.3881.
Cedolini C, Bertozzi S, Londero A, Seriau L, Andretta M, Agakiza D
Int J Clin Exp Pathol. 2016; 8(10):13304-13.
PMID: 26722534
PMC: 4680479.
Hoque M, Prencipe M, Poeta M, Barbano R, Valori V, Copetti M
Cancer Epidemiol Biomarkers Prev. 2009; 18(10):2694-700.
PMID: 19789364
PMC: 4441328.
DOI: 10.1158/1055-9965.EPI-08-0821.
Richards T, Hunt A, Courtney S, Umeh H
Ann R Coll Surg Engl. 2007; 89(2):124-6.
PMID: 17346403
PMC: 1964556.
DOI: 10.1308/003588407X155491.
Jones J
Breast Cancer Res. 2006; 8(2):204.
PMID: 16677423
PMC: 1557717.
DOI: 10.1186/bcr1397.
Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M
Breast Cancer Res. 2005; 7(1):R33-45.
PMID: 15642168
PMC: 1064097.
DOI: 10.1186/bcr948.
The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder S, Ellis I
Breast Cancer Res. 2003; 5(5):254-7.
PMID: 12927035
PMC: 314427.
DOI: 10.1186/bcr623.
Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients.
Morrow M, Venta L, Stinson T, Bennett C
Ann Surg. 2001; 233(4):537-41.
PMID: 11303136
PMC: 1421283.
DOI: 10.1097/00000658-200104000-00009.
Interpretation of the risk associated with the unexpected finding of lobular carcinoma in situ.
Zurrida S, Bartoli C, Galimberti V, Raselli R, Barletta L
Ann Surg Oncol. 1996; 3(1):57-61.
PMID: 8770303
DOI: 10.1007/BF02409052.
Management of in situ and minimally invasive breast carcinoma.
Frykberg E, Bland K
World J Surg. 1994; 18(1):45-57.
PMID: 8197776
DOI: 10.1007/BF00348191.
Metastatic potential of small and minimally invasive breast carcinomas.
Sinn H, Oelmann A, Anton H, Diel I
Virchows Arch. 1994; 425(3):237-41.
PMID: 7812508
DOI: 10.1007/BF00196145.
Management of ductal carcinoma in situ of the breast.
Carty N, Carter C, Royle G, Johnson C
Ann R Coll Surg Engl. 1995; 77(3):163-7.
PMID: 7598411
PMC: 2502099.
Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud?.
Fentiman I
Br J Cancer. 1990; 61(6):795-6.
PMID: 2164832
PMC: 1971702.
DOI: 10.1038/bjc.1990.179.
Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer.
Campbell I, Theaker J, Royle G, Coddington R, Carpenter R, Herbert A
J R Soc Med. 1991; 84(11):652-6.
PMID: 1744869
PMC: 1295466.
DOI: 10.1177/014107689108401108.
